Michaela Medová

Biochemistry, Genetics and Molecular Biology · Life Sciences

23h-index1.4kcitations197works0.62yr avg
OpenAlex↗ORCID↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Virus-based gene therapy research(50), Cancer-related Molecular Pathways(36), Cancer Research and Treatments(31), Liver physiology and pathology(30), Cancer, Hypoxia, and Metabolism(25)

Publications197 total

A Double-Negative Prostate Cancer Subtype is Vulnerable to SWI/SNF-Targeting Degrader Molecules.
Open Access CRIS of the University of Bern·2026Open Access
Multi-layer stratified oncology platform utilizing transcriptomics, prostate cancer organoids, and modeling of drug response
Journal of Experimental & Clinical Cancer Research·2025Open Access
LDHB silencing enhances the effects of radiotherapy by impairing nucleotide metabolism and promoting persistent DNA damage
Scientific Reports·2025· 5 citedOpen Access
Table S2 from E2F1-Associated Purine Synthesis Pathway Is a Major Component of the MET-DNA Damage Response Network
2025Open Access
Figure S1 from E2F1-Associated Purine Synthesis Pathway Is a Major Component of the MET-DNA Damage Response Network
2025Open Access
Figure S1 from E2F1-Associated Purine Synthesis Pathway Is a Major Component of the MET-DNA Damage Response Network
2025Open Access
Figure S2 from E2F1-Associated Purine Synthesis Pathway Is a Major Component of the MET-DNA Damage Response Network
2025Open Access
Figure S3 from E2F1-Associated Purine Synthesis Pathway Is a Major Component of the MET-DNA Damage Response Network
2025Open Access
Table S3 from E2F1-Associated Purine Synthesis Pathway Is a Major Component of the MET-DNA Damage Response Network
2025Open Access
Figure S6 from E2F1-Associated Purine Synthesis Pathway Is a Major Component of the MET-DNA Damage Response Network
2025Open Access
Figure S5 from E2F1-Associated Purine Synthesis Pathway Is a Major Component of the MET-DNA Damage Response Network
2025Open Access
Figure S4 from E2F1-Associated Purine Synthesis Pathway Is a Major Component of the MET-DNA Damage Response Network
2025Open Access
Figure S6 from E2F1-Associated Purine Synthesis Pathway Is a Major Component of the MET-DNA Damage Response Network
2025Open Access
Figure S2 from E2F1-Associated Purine Synthesis Pathway Is a Major Component of the MET-DNA Damage Response Network
2025Open Access
Table S2 from E2F1-Associated Purine Synthesis Pathway Is a Major Component of the MET-DNA Damage Response Network
2025Open Access
Table S1 from E2F1-Associated Purine Synthesis Pathway Is a Major Component of the MET-DNA Damage Response Network
2025Open Access
Table S4 from E2F1-Associated Purine Synthesis Pathway Is a Major Component of the MET-DNA Damage Response Network
2025Open Access
Table S1 from E2F1-Associated Purine Synthesis Pathway Is a Major Component of the MET-DNA Damage Response Network
2025Open Access
Figure S4 from E2F1-Associated Purine Synthesis Pathway Is a Major Component of the MET-DNA Damage Response Network
2025Open Access
Table S3 from E2F1-Associated Purine Synthesis Pathway Is a Major Component of the MET-DNA Damage Response Network
2025Open Access
page 1 of 10Next →

Frequent Co-authors

Yitzhak Zimmer(40), Daniel M. Aebersold(34), Matúš Medo(11), Deborah Stroka(11), Lluís Nisa(9), Paola Francica(8), Andree Blaukat(7), Rahel Riedo(7), Eleonora Orlando(6), Astrid A. Glück(6), Roland Giger(6), Aurélie Quintin(6), Thomas M. Marti(6), Wieslawa Blank-Liss(5), Adrian Keogh(5), Jonas P. Koch(5), Michaela Poliaková(5), Friedhelm Bladt(5), Selina M. Roth(5), Bruno Streit(4)